After the Supreme Court overturned the landmark Roe v. Wade ruling, companies across industries are stepping in to support employees who need to cross state lines for...

With Congress weighing a cap on out-of-pocket costs for insulin for certain individuals, Sanofi has beaten the government to the punch. The Paris-based company sa...

Johnson & Johnson is boosting its “Positively Fearless” HIV campaign as it looks to break the old stigma attached to the disease whilst boosting its outreach into...

Fujifilm isn’t slowing down on its expansion roll. Just a few months after it bought Shenandoah Biotechnology for an undisclosed sum, the Japanese conglomerate has un...

For months, Novartis has hinted at layoffs coming for some of its global staff. Now, the news has come down from HQ. Novartis is laying off around 8,000 of its 10...

It turns out that even more than the blinding pain, the nausea, the photosensitivity or crushing fatigue, the worst part of migraine is often the stigma attached to i...

This spring, when the FDA pushed its target date for pediatric approval of Merck’s pneumococcal vaccine Vaxneuvance back by 90 days, it was a blow to the company’s ho...

As authorities continue to probe irregularities in the HIV drug supply chain, a Florida man has been arrested for his alleged role in a nationwide scheme to defraud t...

Bristol Myers Squibb, Pfizer and Merck will face extreme patent cliff exposure later in this decade. But those companies also have the financial flexibility to perfor...

While GSK has trimmed some staffers at Barnard Castle in recent years, it's still investing in next-gen manufacturing at the U.K. site. The British Big Pharma has...